POLE and cancer: The risk score was associated with molecular subtypes (p < 0.01), cancer status (p < 0.01) and age (p = 0.03), in EEA patients, POLE hypermutation and MSI subtypes have low risk values, while high CNV is associated with high-risk values (Figure 3A).